Hope to See You In-Person at an Upcoming Event!
PAAS National® will be at the following upcoming events and we hope to see you in-person.
Entries by Stacy Wilk
Excluded Individual Creates Chaos for A Pharmacy IF Not Caught Right Away!
Recently PAAS identified an excluded individual as an exact match through our proprietary exclusion checking offered by the Fraud, Waste & Abuse and HIPAA Compliance Program.
On-Demand Webinar: Compliance Issues, HIPAA Enforcement and Audit Risks with COVID-19
On April 7, 2022 PAAS National® hosted Compliance Issues, HIPAA Enforcement and Audit Risks with COVID-19 webinar.
LIVE WEBINAR APRIL 7th: Compliance Issues, HIPAA Enforcement and Audit Risks with COVID-19
Join President of PAAS National®, Trenton Thiede, PharmD, MBA as he discusses compliance program requirements, recent HIPAA enforcement/action, COVID-19 vaccine audit risks, OTC COVID-19 tests audit risks (and Medicare B guidance) and onsite audit preparation.
Four Tips for Navigating Pharmacy Compliance Audits in 2022
Compliance audits launched by pharmacy benefit managers (PBMs) have long been a cause of frustration for pharmacies, especially independent community pharmacies with limited manpower and resources compared to large chains.
Top 3 PAAS eNewsline Exclusive Articles
PAAS Audit Assistance member can explore additional eNewsline articles on the PAAS Member Portal.
Top 10 PAAS National Articles of 2021
PAAS Audit Assistance members receive a monthly newsletter with new audit tactics and prevention tips.
2022 Fraud, Waste & Abuse and HIPAA Compliance Program Updates
The PAAS National® FWA/HIPAA Compliance Program has implemented changes to ensure pharmacies continue to have a robust program i
Humana Compliance Requirements – Training and Exclusion Checks Are Not Enough
PAAS analysts have received several questions regarding Humana’s 2022 Notice of Program Requirements.
New OTC COVID-19 Resources for Community Pharmacies
On February 2, PAAS National® announced new COVID-19 resources for PAAS Audit Assistance members to aid in billing commercial third-parties for OTC COVID-19 tests.
